Century Therapeutics, Inc. (IPSC) Free cash flow 2020–2025
Century Therapeutics, Inc. (IPSC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$104.7MFY2025 · since FY2020: -$51.1M → -$104.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$104.7M | +5.0% |
| FY2024 | -$110.3M | -8.0% |
| FY2023 | -$102.1M | -516.7% |
| FY2022 | -$16.6M | +87.6% |
| FY2021 | -$134.0M | -162.2% |
| FY2020 | -$51.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice